MiR-223 inhibits dengue virus replication by negatively regulating the microtubule-destabilizing protein STMN1 in EAhy926cells

Microbes and Infection

Volumn 16, Issue 11, 2014, Pages 911-922

  Wu, Na ^a   Gao, Na ^a   Fan, Dongying ^a   Wei, Jianchun ^a   Zhang, Jing ^a   An, Jing ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE FOR BRAIN DISORDERS   (China)

Author keywords

C EBP ; Dengue virus; E2F1; MiR 223; STMN1

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; MESSENGER RNA; MICRORNA 223; MICROTUBULE PROTEIN; NONSTRUCTURAL PROTEIN 1; STATHMIN; STATHMIN 1; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MICRORNA; MIRN223 MICRORNA, HUMAN; STMN1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ANIMAL TISSUE; ARTICLE; BINDING SITE; DENGUE; DENGUE VIRUS 2; DNA METHYLATION; DOWN REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; HEPG2 CELL LINE; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; VERO CELL LINE; VIRUS RELEASE; VIRUS REPLICATION; ANTAGONISTS AND INHIBITORS; CELL LINE; DENGUE VIRUS; ENDOTHELIUM CELL; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MICROTUBULE; PHYSIOLOGY; PROTEIN SYNTHESIS; RNA STABILITY; VIROLOGY;

DENGUE VIRUS;

3' UNTRANSLATED REGIONS; CELL LINE; DENGUE VIRUS; ENDOTHELIAL CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; MICRORNAS; MICROTUBULES; PROTEIN BIOSYNTHESIS; RNA STABILITY; RNA, MESSENGER; STATHMIN; VIRUS REPLICATION;

EID: 84919473480     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2014.08.011     Document Type: Article

References (42)

1. Guzman M.G., Halstead S.B., Artsob H., Buchy P., Farrar J., Gubler D.J., et al. Dengue: a continuing global threat, nature reviews. Microbiology 2010, 8:S7-S16.
2. Bhatt S., Gething P.W., Brady O.J., Messina J.P., Farlow A.W., Moyes C.L., et al. The global distribution and burden of dengue. Nature 2013, 496:504-507.
3. Basu A., Chaturvedi U.C. Vascular endothelium: the battlefield of dengue viruses. FEMS Immunol Med Microbiol 2008, 53:287-299.
4. Kuhn R.J., Zhang W., Rossmann M.G., Pletnev S.V., Corver J., Lenches E., et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 2002, 108:717-725.
5. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
6. Reis L.O., Pereira T.C., Lopes-Cendes I., Ferreira U. MicroRNAs: a new paradigm on molecular urological oncology. Urology 2010, 76:521-527.
7. Cullen B.R. Transcription and processing of human microRNA precursors. Mol Cell 2004, 16:861-865.
8. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
9. Wang D., Cao L., Xu Z., Fang L., Zhong Y., Chen Q., et al. MiR-125b reduces porcine reproductive and respiratory syndrome virus replication by negatively regulating the NF-kappaB pathway. PLoS One 2013, 8:e55838.
10. Jopling C.L., Yi M., Lancaster A.M., Lemon S.M., Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005, 309:1577-1581.
11. Lecellier C.H., Dunoyer P., Arar K., Lehmann-Che J., Eyquem S., Himber C., et al. A cellular microRNA mediates antiviral defense in human cells. Science 2005, 308:557-560.
12. Skalsky R.L., Corcoran D.L., Gottwein E., Frank C.L., Kang D., Hafner M., et al. The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog 2012, 8:e1002484.
13. Cameron J.E., Fewell C., Yin Q., McBride J., Wang X., Lin Z., et al. Epstein-Barr virus growth/latency III program alters cellular microRNA expression. Virology 2008, 382:257-266.
14. Motsch N., Pfuhl T., Mrazek J., Barth S., Grasser F.A. Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol 2007, 4:131-137.
15. Triboulet R., Mari B., Lin Y.L., Chable-Bessia C., Bennasser Y., Lebrigand K., et al. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 2007, 315:1579-1582.
16. Qi Y., Li Y., Zhang L., Huang J. microRNA expression profiling and bioinformatic analysis of dengue virusinfected peripheral blood mononuclear cells. Mol Med Rep 2013, 7:791-798.
17. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
18. Fazi F., Racanicchi S., Zardo G., Starnes L.M., Mancini M., Travaglini L., et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 2007, 12:457-466.
19. Fazi F., Rosa A., Fatica A., Gelmetti V., De Marchis M.L., Nervi C., et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 2005, 123:819-831.
20. Pulikkan J.A., Dengler V., Peramangalam P.S., Peer Zada A.A., Muller-Tidow C., Bohlander S.K., et al. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 2010, 115:1768-1778.
21. Eyholzer M., Schmid S., Schardt J.A., Haefliger S., Mueller B.U., Pabst T. Complexity of miR-223 regulation by CEBPA in human AML. Leuk Res 2010, 34:672-676.
22. Valdez C.D., Kunju L., Daignault S., Wojno K.J., Day M.L. The E2F1/DNMT1 axis is associated with the development of AR negative castration resistant prostate cancer. Prostate 2013, 73:1776-1785.
23. Li Y., Chan E.Y., Li J., Ni C., Peng X., Rosenzweig E., et al. MicroRNA expression and virulence in pandemic influenza virus-infected mice. J Virol 2010, 84:3023-3032.
24. Wang X., Ye L., Hou W., Zhou Y., Wang Y.J., Metzger D.S., et al. Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood 2009, 113:671-674.
25. Xu J., Wu C., Che X., Wang L., Yu D., Zhang T., et al. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 2011, 50:136-142.
26. Hussain M., Asgari S. MicroRNA-like viral small RNA from Dengue virus 2 autoregulates its replication in mosquito cells. Proc Natl Acad Sci U S A 2014, 111:2746-2751.
27. Felli N., Pedini F., Romania P., Biffoni M., Morsilli O., Castelli G., et al. MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis. Haematologica 2009, 94:479-486.
28. Johnnidis J.B., Harris M.H., Wheeler R.T., Stehling-Sun S., Lam M.H., Kirak O., et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008, 451:1125-1129.
29. Karakatsanis A., Papaconstantinou I., Gazouli M., Lyberopoulou A., Polymeneas G., Voros D. Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog 2013, 52:297-303.
30. Mallick B., Ghosh Z., Chakrabarti J. MicroRNome analysis unravels the molecular basis of SARS infection in bronchoalveolar stem cells. PloS One 2009, 4:e7837.
31. Yoshie M., Miyajima E., Kyo S., Tamura K. Stathmin, a microtubule regulatory protein, is associated with hypoxia-inducible factor-1alpha levels in human endometrial and endothelial cells. Endocrinology 2009, 150:2413-2418.
32. Hsu H.P., Li C.F., Lee S.W., Wu W.R., Chen T.J., Chang K.Y., et al. Overexpression of stathmin 1 confers an independent prognostic indicator in nasopharyngeal carcinoma. Tumour Biol 2014, 35:2619-2629.
33. Ke B., Wu L.L., Liu N., Zhang R.P., Wang C.L., Liang H. Overexpression of stathmin 1 is associated with poor prognosis of patients with gastric cancer. Tumour Biol: J Int Soc Oncodevelop Biol Med 2013, 34:3137-3145.
34. Watanabe A., Suzuki H., Yokobori T., Tsukagoshi M., Altan B., Kubo N., et al. Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma. Cancer Sci 2014, 105:690-696.
35. McCartney E.M., Helbig K.J., Narayana S.K., Eyre N.S., Aloia A.L., Beard M.R. Signal transducer and activator of transcription 3 is a proviral host factor for hepatitis C virus. Hepatology 2013, 58:1558-1568.
36. Hoang L.T., Lynn D.J., Henn M., Birren B.W., Lennon N.J., Le P.T., et al. The early whole-blood transcriptional signature of dengue virus and features associated with progression to dengue shock syndrome in Vietnamese children and young adults. J Virol 2010, 84:12982-12994.
37. Arcangeletti M.C., Pinardi F., Missorini S., De Conto F., Conti G., Portincasa P., et al. Modification of cytoskeleton and prosome networks in relation to protein synthesis in influenza A virus-infected LLC-MK2 cells. Virus Res 1997, 51:19-34.
38. Wang J.L., Zhang J.L., Chen W., Xu X.F., Gao N., Fan D.Y., et al. Roles of small GTPase Rac1 in the regulation of actin cytoskeleton during dengue virus infection. PLoS Negl Trop Dis 2010, 4.
39. Radomska H.S., Huettner C.S., Zhang P., Cheng T., Scadden D.T., Tenen D.G. CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol 1998, 18:4301-4314.
40. Lee S., Chun J.N., Kim S.H., So I., Jeon J.H. Icilin inhibits E2F1-mediated cell cycle regulatory programs in prostate cancer. Biochem Biophys Res Commun 2013, 441:1005-1010.
41. Weber B., Stresemann C., Brueckner B., Lyko F. Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle 2007, 6:1001-1005.
42. Lujambio A., Ropero S., Ballestar E., Fraga M.F., Cerrato C., Setien F., et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 2007, 67:1424-1429.